Calidi Biotherapeutics (CLDI) Gains from Investment Securities (2022 - 2023)
Calidi Biotherapeutics (CLDI) posted quarterly Gains from Investment Securities of $1.3 million for Q2 2023, up 131.78% year-over-year from $552474.6 in Q2 2022, and up 1546.89% quarter-over-quarter from -$88500.0 in Q1 2023.
Calidi Biotherapeutics (CLDI) Gains from Investment Securities (2022 - 2023) Analysis & Trends
Calidi Biotherapeutics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $1.3 million for Q2 2023.
- In Q2 2023, Gains from Investment Securities rose 131.78% year-over-year to $1.3 million; the TTM figure through Jun 2023 stood at $592000.0 (changed N/A YoY), while the FY2022 annual figure was -$6.7 million, down 18.93% from the prior year.
- Gains from Investment Securities for Q2 2023 stood at $1.3 million, up from -$88500.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.3 million in Q2 2023, with the low at -$4.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | -88,500.00 |
| Mar 31, 2023 | -88,500.00 |
| Dec 31, 2022 | -140,000.00 |
| Dec 31, 2022 | -140,000.00 |
| Sep 30, 2022 | -460,000.00 |
| Sep 30, 2022 | -460,000.00 |
| Jun 30, 2022 | -4.03 Mn |
| Jun 30, 2022 | -4.03 Mn |
| Mar 31, 2022 | -2.09 Mn |
| Mar 31, 2022 | -2.09 Mn |